Bing Xu

Running trials

• Recruiting

  Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

  NCT06826118· Phase 2· Source

• Recruiting

  Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma

  NCT06553352· Phase 2· Source

• Recruiting

  68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

  NCT06151119· Source

• Recruiting

  All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma

  NCT06158412· Phase 2· Source

• Recruiting

  Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma

  NCT06158386· Phase 2· Source

• Recruiting

  AZA Combined With RCHOP in P53-mutated DLBCL.

  NCT06158399· Phase 2· Source

• Recruiting

  Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

  NCT06151080· Phase 2· Source

• Recruiting

  VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

  NCT05603884· Phase 2· Source

• Recruiting

  Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

  NCT06827899· Phase 2· Source

• Recruiting

  Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML

  NCT05305859· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Follicular lymphoma4 recruiting
• Acute myeloid leukemia3 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Multiple myeloma1 recruiting
• Myeloproliferative neoplasms1 recruiting

Researchers

No researcher is linked here yet.